LOS ANGELES--(BUSINESS WIRE)--The Southern California Biomedical Council (SoCalBio) — the voice and advocate for the bioscience and digital health industries in the Greater Los Angeles region — today announced the preliminary lineup of companies selected to present at the 22nd Annual SoCalBio Conference (www.SoCalBioInvest.com).
This year’s Conference will be held online October 21 - 23 with four parallel tracks of presentations and panel discussions. Topics will focus on the latest technology trends and business development/partnership opportunities in fields such as immunotherapy, COVID-19 diagnostics and therapeutics, drug delivery, bioelectronic medicine and AI (artificial intelligence). The Conference program and agenda are available at www.SoCalBioInvest.com/Program
One of the tracks (Track II: Nurturing Innovators) will showcase emerging companies. In all, about 30 startups will present to investors and potential partners. The full schedule of presentations is available at https://socalbio.org/wordpress/wp-content/uploads/2020/10/List-of-Company-Presentations-1.pdf
“In response to COVID-19 we have been forced to reimagine the SoCalBio Conference, which has allowed us to expand our lineup of world-class companies, speakers and business development opportunities,” said SoCalBio President and CEO Ahmed Enany. “While the format is new, this year’s online Conference retains our focus on showcasing the best and brightest minds in the L.A. region’s bioscience industry.”
The preliminary list of presenting companies includes:
- 3VO Medical (Novel medical device therapy to improve labor and newborn delivery)
- Arcutis Biotherapeutics (Treatment of immune-modulated dermal disease)
- Aevum Therapeutics (Therapeutics to treat neurodegenerative disorders)
- Allevion Therapeutic (Neuromodulation device to treat essential tremors)
- Aqualung Therapeutics (Treatment of inflammation)
- BioDesigns, Inc. (High-fidelity prosthetics with osseo-stabilization and osseo-synchronization technology)
- Brinter (3D bio-printing)
- Carlsmed (Data-driven spine surgery)
- cBio (Membrane-free enrichment of nano and microparticles)
- Ecovia Renewables (Bio-based ingredients and materials)
- Forcyte Biotechnologies (Treatment of diseases of cell mechanobiology by directly screening contractile cell force)
- Hura Imaging (Patented technology to reduce exposure to radiation during CT scans)
- Inmedix, Inc. (Autonomics for managing autoimmune diseases)
- iPill (Device to reduce opioid diversion and abuse)
- iRegained (Proprietary targeted hand function rehabilitation system to restore lost hand function in stroke or brain trauma survivors)
- Iridia (DNA-based data storage solutions)
- KA Imaging (FDA-cleared portable multi-energy X-ray detector that enables soft tissue differentiation)
- LIPAC Oncology (Clinical stage patented proliposomal drug delivery platform to deliver cancer treatments in large unmet markets)
- Matregenix (Technology to unlock nanofibers’ potential)
- Milo Sensors (Wearable device for continued enzymatic alcohol sensing in blood)
- OtoNexus (Novel ultrasound device to instantly and accurately evaluate middle ear infections)
- Pictor Labs (Virtual histopathology)
- Pure Spun Innovation (Novel water purification technology)
- Remmie (AI-enabled otoscope for tracking ear infections)
- SilkTech Biopharmaceuticals (Novel silk-derived anti-inflammatory protein)
- Standard Cytopedia Inc. (Liquid biopsy-based tests using proprietary “Rare Cell Sorting” technology for clinical diagnostics in cancer and prenatal testing)
- TAE Life Sciences (Novel radiotherapy based on Boron Neutron Capture Therapy)
The companies were selected from a large pool of applicants by members of SoCalBio’s Innovation Catalyst Program, a unique network of senior bioscience and healthcare professionals who provide presentation and business coaching for SoCalBio Conference presenters.
“The Annual SoCalBio Conference is a unique opportunity for emerging Southern California healthcare companies to present their vision to investors,” said Peter Blaisdell, PhD, Chairperson of the SoCalBio Innovation Catalyst Program. “Beyond funding, the conference allows participating companies to build relationships with industry peers and allied service providers vital to their growth.”
Pre-registration is required to attend the Conference. More information is available at http://socalbioinvest.com/register.
All Conference sessions and company presentations will be streamed live to attendees via the Whova Platform, which enables participants to:
- Access the list of conference attendees
- Request one-on-one meetings
- Create virtual meetup rooms
- Access conference materials and recorded sessions
- Design exhibits to enhance visibility and attract potential business partners
- Announce job openings
- Share literature and other business-related collateral
When attendees register for the Conference, they receive email instructions for accessing Whova and downloading the event's mobile app. To maximize the virtual experience, the Whova platform will be accessible 24/7 for six months after the conference.
SoCalBio welcomes support from the following Conference sponsors:
- Amgen
- AMI – USC
- Perkins Coie
- VWR
- Consulate General of Canada in Los Angeles
- CBIZ
- TriNet
- American Express
- Century Business Services
About SoCalBio
SoCalBio is a nonprofit, member-supported trade association that promotes bioscience research, development, manufacturing, job creation and overall economic growth in the Greater Los Angeles region. The Council’s programs help local firms gain access to capital, potential partners and business support services. SoCalBio also promotes technology transfer and workforce training, while informing policymakers and the public-at-large about the benefits of the L.A. region’s life-science industry. More information about SoCalBio is available at www.socalbio.org.
